The development of these histological subtypes occurs through the progressive accumulation of genetic and epigenetic events, with inactivating mutations in the p53 tumour suppressor detected in >50% of the cases, being common to all subtypes [1,2,3,4,5,6,7,8,9]. Here, TP53 is linked to neoplasm.